Dynamic SMAD–RUNX2 complexes orchestrate breast cancer bone metastasis
Abstract
Experimental & Molecular Medicine, Published online: 09 November 2026; doi:10.1038/s12276-026-01883-0 Bone metastasis is a significant complication of breast cancer, severely impacting patients' quality of life and survival. This study explores the roles of SMAD1–RUNX2 and SMAD2/3–RUNX2 complexes in breast cancer bone metastasis. Researchers used breast cancer cells with wild-type or mutated RUNX2 to analyze the effects of these complexes under TGFβ and BMP treatments. They found that SMAD2/3–RUNX2 promotes cancer cell migration to bone, while SMAD1–RUNX2 enhances cell adhesion to bone. These complexes differentially regulate gene expression related to metastasis, with SMAD2/3–RUNX2 facilita